[1]
H. Al-Nayyar and K. Ben-Mahrez, “GPX1 genetic variants rs2107819200 and rs1575633487 in disease status and tyrosine kinase inhibitor response in chronic myeloid leukemia patients”, Regul. Mech. Biosyst., vol. 16, no. 3, p. e25128, Oct. 2025.